Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01330134 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Lidocaine Administration Techniques
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 481
- Enrollment target
NCT01330134 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 481 participants.
The verdict
NCT01330134, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 481 participants
- Enrollment target
Study Summary
The objective of our study is to determine if technique of lidocaine administration can decrease pain perception. Hypothesis: There will be a significant difference in pain perception between patients who are given lidocaine on the skin surface prior to subcutaneous injection and patients who are given only subcutaneous injection by standard approach.
Interventions
- DRUG lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 481 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01330134
The ClinicalTrials.gov registry entry for NCT01330134 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 481 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lidocaine is the first listed.
NCT01330134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01330134 about?
NCT01330134 is a clinical study titled "Comparison of Two Lidocaine Administration Techniques". The objective of our study is to determine if technique of lidocaine administration can decrease pain perception. Hypothesis: There will be a significant difference in pain perception between patients who are given lidocaine on the skin surface prior to subcutaneous injection and patients who are g...
What is the current status of trial NCT01330134?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 481 participants. The study started on 2011-02. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01330134?
The interventions under investigation include: lidocaine (DRUG).
Who is sponsoring clinical trial NCT01330134?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.